|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
9,230,000 |
Market
Cap: |
3.60(M) |
Last
Volume: |
426,351 |
Avg
Vol: |
425,178 |
52
Week Range: |
$0.39 - $0.39 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company working to develop cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin Dependent Kinase 2/9 (CDK2/9) inhibitor, in solid tumors and hematological malignancies. The anti-mitotic program is evaluating CYC140, a Polo-Like-Kinase 1(PLK 1) inhibitor, in cancers. CDKs are a family of enzymes discovered as regulators of the cell cycle. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle, and is a regulator of the DNA damage checkpoint.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
7,956 |
7,956 |
7,956 |
Total Buy Value |
$0 |
$26,374 |
$26,374 |
$26,374 |
Total People Bought |
0 |
2 |
2 |
2 |
Total Buy Transactions |
0 |
2 |
2 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rombotis Spiro |
President and C.E.O. |
|
2011-09-23 |
4 |
B |
$3.06 |
$3,670 |
D/D |
1,200 |
1,600 |
2.73 |
- |
|
Rombotis Spiro |
President and C.E.O. |
|
2011-09-23 |
4 |
B |
$0.51 |
$12,171 |
D/D |
24,100 |
608,530 |
2.81 |
- |
|
Mcbarron Paul |
EVP, Finance, CFO, COO |
|
2011-09-23 |
4 |
B |
$0.50 |
$6,000 |
D/D |
12,000 |
188,054 |
2.81 |
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-09-22 |
4 |
S |
$0.60 |
$302,350 |
I/I |
(500,000) |
3,456,900 |
|
- |
|
Rombotis Spiro |
President and C.E.O. |
|
2011-09-22 |
4 |
B |
$0.59 |
$2,965 |
D/D |
5,000 |
584,430 |
2.73 |
- |
|
Rombotis Spiro |
President & C.E.O. |
|
2011-09-13 |
4 |
B |
$3.23 |
$1,291 |
D/D |
400 |
400 |
2.73 |
- |
|
Rombotis Spiro |
President & C.E.O. |
|
2011-09-13 |
4 |
B |
$0.67 |
$8,052 |
D/D |
12,000 |
579,430 |
2.81 |
- |
|
Rombotis Spiro |
President & C.E.O. |
|
2011-08-22 |
4 |
B |
$0.73 |
$6,721 |
D/D |
9,232 |
567,430 |
2.81 |
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2011-05-13 |
4 |
S |
$1.73 |
$263,200 |
I/I |
(150,000) |
3,956,900 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2010-11-30 |
4 |
S |
$1.90 |
$269,871 |
I/I |
(142,000) |
4,106,900 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2010-11-26 |
4 |
S |
$1.90 |
$110,310 |
I/I |
(58,000) |
4,248,900 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2010-10-08 |
4 |
S |
$1.67 |
$307,728 |
I/I |
(183,982) |
4,306,900 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2010-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,490,882 |
|
- |
|
Rombotis Spiro |
President & C.E.O. |
|
2010-06-09 |
4 |
OE |
$0.44 |
$33,000 |
D/D |
75,000 |
558,198 |
|
- |
|
Sosnowski Robert Edward |
VP, Sales & Marketing |
|
2010-05-04 |
4 |
AS |
$2.50 |
$25,000 |
D/D |
(10,000) |
0 |
|
- |
|
Sosnowski Robert Edward |
VP, Sales & Marketing |
|
2010-05-04 |
4 |
OE |
$0.44 |
$4,400 |
D/D |
10,000 |
10,000 |
|
- |
|
Rombotis Spiro |
President & C.E.O. |
|
2010-04-23 |
4 |
AS |
$2.50 |
$20,875 |
D/D |
(8,350) |
483,198 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2010-01-07 |
4 |
S |
$1.54 |
$358,030 |
I/I |
(232,487) |
2,441,837 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2010-01-06 |
4 |
S |
$1.14 |
$124,288 |
I/I |
(108,900) |
2,674,324 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2009-12-11 |
4 |
S |
$1.29 |
$1,299,703 |
I/I |
(1,009,400) |
2,783,224 |
|
- |
|
Marxe Austin W & Greenhouse David M |
10% Owner |
|
2009-12-10 |
4 |
S |
$1.07 |
$214,695 |
I/I |
(200,000) |
3,792,624 |
|
- |
|
Morgan Stanley |
10% Owner |
|
2009-11-10 |
4 |
S |
$0.80 |
$263,080 |
I/I |
(328,850) |
2,276,852 |
|
- |
|
Morgan Stanley |
10% Owner |
|
2009-11-09 |
4 |
S |
$0.86 |
$40,463 |
I/I |
(47,050) |
2,605,702 |
|
- |
|
Morgan Stanley |
10% Owner |
|
2009-11-06 |
4 |
S |
$0.86 |
$20,726 |
I/I |
(24,100) |
2,652,752 |
|
- |
|
Morgan Stanley |
10% Owner |
|
2009-11-05 |
4 |
S |
$0.88 |
$90,791 |
I/I |
(103,172) |
2,676,852 |
|
- |
|
281 Records found
|
|
Page 3 of 12 |
|
|